Aveanna Healthcare (NASDAQ:AVAH) Sets New 1-Year High at $5.95

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHGet Free Report) shares hit a new 52-week high on Monday . The company traded as high as $5.95 and last traded at $5.44, with a volume of 48044 shares trading hands. The stock had previously closed at $5.52.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on AVAH shares. Royal Bank of Canada raised their price target on Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “sector perform” rating in a research note on Friday, August 9th. UBS Group boosted their price target on Aveanna Healthcare from $1.70 to $2.80 and gave the company a “sell” rating in a research note on Friday, August 9th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “buy” rating in a report on Friday, August 9th.

Read Our Latest Stock Analysis on Aveanna Healthcare

Aveanna Healthcare Stock Up 2.8 %

The company has a fifty day simple moving average of $4.85 and a 200-day simple moving average of $3.35. The firm has a market cap of $1.08 billion, a P/E ratio of -9.32 and a beta of 2.13.

Aveanna Healthcare (NASDAQ:AVAHGet Free Report) last released its earnings results on Thursday, August 8th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.03. The firm had revenue of $504.96 million during the quarter, compared to analysts’ expectations of $494.02 million. As a group, research analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.09 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Acadian Asset Management LLC boosted its stake in shares of Aveanna Healthcare by 185.6% in the first quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock worth $72,000 after acquiring an additional 19,096 shares during the period. Mackenzie Financial Corp grew its holdings in Aveanna Healthcare by 35.9% during the 2nd quarter. Mackenzie Financial Corp now owns 45,674 shares of the company’s stock valued at $126,000 after buying an additional 12,075 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Aveanna Healthcare by 6.6% during the second quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock valued at $413,000 after buying an additional 9,243 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Aveanna Healthcare by 155.8% in the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after buying an additional 96,600 shares in the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Aveanna Healthcare by 1.8% during the first quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after acquiring an additional 44,970 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Read More

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.